SOLENO THERAPEUTICS INC — Income Charts
50 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$92M
Cost of Revenue
$863K
Gross Profit↑+16.3% +$8K
$-41K
R&D↓-55.5% -$12M
$10M
SG&A↑+9.6% +$4M
$41M
D&A↑+1.2% +$6K
$509K
Operating Income↑+127.6% +$102M
$22M
EBITDA↑+1.2% +$6K
$509K
Interest Expense
$1M
Interest Income↑+52.5% +$2M
$5M
Net Income
$43M
Gross Margin↓-1650.0pts
-4100.0%
Operating Margin
33.5%
Net Margin
47.3%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-2.4pts
-2.1%
ETR Foreign Differential (pp)↓-0.6pts
-0.6%
Operating Lease Cost↓-29.6% -$76K
$181K
Revenue YoY Variation↑+47.9pts
-50.0%
Income YoY Variation↑+800.2pts
127.6%
Revenue QoQ Variation
38.9%
Income QoQ Variation↑+661.3pts
438.8%